3 Safety Profile of Casdatifan Monotherapy in Patients with Clear Cell Renal Cell Carcinoma: Pooled Analysis of the ARC-20 Study (NCT05536141)
Rana McKay, Jamie Merchan, Amita Patnaik, Alexandra Drakaki, Brian Rini, Sun Young Rha, Jae Lyun Lee, Moshe Ornstein, Rohit Kumar, Clara Hwang, Yusra Shao, Se Hoon Park, Pedro Barata, Bradley McGregor, Jianfen Chen, Melissa Eisen, Syed Quadri, Paul Foster, Toni Choueiri · 2026
Read 3 Safety Profile of Casdatifan Monotherapy in Patients with Clear Cell Renal Cell Carcinoma: Pooled Analysis of the ARC-20 Study (NCT05536141) by Rana McKay, Jamie Merchan, Amita Patnaik, Alexandra Drakaki, Brian Rini, Sun Young Rha, Jae Lyun Lee, Moshe Ornstein, Rohit Kumar, Clara Hwang, Yusra Shao, Se Hoon Park, Pedro Barata, Bradley McGregor, Jianfen Chen, Melissa Eisen, Syed Quadri, Paul Foster, Toni Choueiri (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13535363.txt.
Description
Rana McKay and co-authors detail the safety record of a new kidney cancer drug, casdatifan, in a 2026 conference report. The drug blocks HIF-2 alpha, a switch that runs wild in clear cell kidney cancer and drives growth and spread. Early results had shown real anti-tumor action in patients who had already failed two drug classes. This pooled read checks harm across the ARC-20 study.
The main set held 32 patients on the chosen dose, inside 127 treated at any dose. Nearly all had some side effect, and half to three fifths had a severe one. Dose cuts came for about a quarter, most often for anemia or low blood oxygen, the drug's known on-target harms. Only a small share quit for side effects, and no deaths were tied to the drug. Most low-oxygen cases eased with added oxygen.
Catalog record
| CREATOR | Rana McKay, Jamie Merchan, Amita Patnaik, Alexandra Drakaki, Brian Rini, Sun Young Rha, Jae Lyun Lee, Moshe Ornstein, Rohit Kumar, Clara Hwang, Yusra Shao, Se Hoon Park, Pedro Barata, Bradley McGregor, Jianfen Chen, Melissa Eisen, Syed Quadri, Paul Foster, Toni Choueiri |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 4 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |